Clinical Trial Update: Upadacitinib in Giant Cell Arteritis (GCA) With Active Large-vessel Involvement.

View source ↗

Summary

A clinical trial is evaluating upadacitinib for Giant Cell Arteritis with active large-vessel involvement (NCT07354906), sponsored by Groupe français d'étude de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil | Conditions: Giant Cell Arteritis (GCA) | Status: NOT_YET_RECRUITING